Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury

Details for Australian Patent Application No. 2005309733 (hide)

Owner Celgene Corporation

Inventors Faleck, Herbert; Zeldis, Jerome; Manning, Donald C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005309733

PCT Pub. Number WO2006/058008

Priority 60/630,599 23.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/454 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/058008 Priority application(s): WO2006/058008

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309737-Niacin receptor agonists, compositions containing such compounds and methods of treatment

2005309732-JNK inhibitors for treatment of CNS injury